Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nuclear Physics | 6 | 2014 | 73 | 0.650 |
Why?
|
Elementary Particles | 4 | 2014 | 50 | 0.440 |
Why?
|
Myeloproliferative Disorders | 4 | 2015 | 615 | 0.420 |
Why?
|
Chromosome Aberrations | 4 | 2013 | 1774 | 0.400 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 2 | 2023 | 172 | 0.380 |
Why?
|
Hormone Replacement Therapy | 1 | 2016 | 752 | 0.350 |
Why?
|
Decidua | 1 | 2011 | 80 | 0.350 |
Why?
|
Abortion, Habitual | 1 | 2011 | 65 | 0.350 |
Why?
|
Cesarean Section, Repeat | 1 | 2009 | 32 | 0.320 |
Why?
|
Calreticulin | 3 | 2014 | 111 | 0.310 |
Why?
|
Receptors, Progesterone | 1 | 2013 | 1152 | 0.310 |
Why?
|
Thrombocythemia, Essential | 3 | 2014 | 114 | 0.300 |
Why?
|
Arsenic | 1 | 2012 | 357 | 0.300 |
Why?
|
Water Pollutants, Chemical | 1 | 2012 | 359 | 0.290 |
Why?
|
Leukemia, Myeloid, Acute | 5 | 2024 | 3640 | 0.280 |
Why?
|
Models, Theoretical | 6 | 2014 | 3563 | 0.280 |
Why?
|
Receptors, Estrogen | 2 | 2022 | 2240 | 0.270 |
Why?
|
Placenta Diseases | 1 | 2009 | 199 | 0.270 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2011 | 518 | 0.270 |
Why?
|
Neuroblastoma | 4 | 2022 | 1263 | 0.250 |
Why?
|
Primary Myelofibrosis | 4 | 2014 | 210 | 0.240 |
Why?
|
Neoplasms, Second Primary | 1 | 2012 | 1048 | 0.230 |
Why?
|
Hypereosinophilic Syndrome | 2 | 2015 | 97 | 0.220 |
Why?
|
Elementary Particle Interactions | 2 | 2013 | 17 | 0.210 |
Why?
|
Janus Kinase 2 | 4 | 2014 | 562 | 0.210 |
Why?
|
Receptor, erbB-2 | 1 | 2013 | 2592 | 0.210 |
Why?
|
Barth Syndrome | 1 | 2022 | 25 | 0.200 |
Why?
|
Killer Cells, Natural | 1 | 2011 | 2207 | 0.190 |
Why?
|
Epigenesis, Genetic | 2 | 2022 | 3818 | 0.180 |
Why?
|
Acyltransferases | 1 | 2022 | 305 | 0.170 |
Why?
|
Registries | 2 | 2017 | 8293 | 0.170 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2023 | 385 | 0.170 |
Why?
|
Neutrophils | 2 | 2023 | 3772 | 0.170 |
Why?
|
Candidiasis | 1 | 2022 | 371 | 0.160 |
Why?
|
Toll-Like Receptors | 1 | 2022 | 583 | 0.150 |
Why?
|
Receptors, Thrombopoietin | 3 | 2013 | 157 | 0.140 |
Why?
|
DNA Replication | 1 | 2024 | 1432 | 0.140 |
Why?
|
Mesons | 2 | 2014 | 28 | 0.140 |
Why?
|
Neutropenia | 1 | 2022 | 893 | 0.130 |
Why?
|
Myositis Ossificans | 1 | 2017 | 76 | 0.130 |
Why?
|
Leukemia | 2 | 2022 | 1522 | 0.130 |
Why?
|
Oncogenes | 1 | 2022 | 1232 | 0.130 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2015 | 1608 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-cbl | 2 | 2013 | 120 | 0.130 |
Why?
|
DNA Modification Methylases | 1 | 2015 | 207 | 0.120 |
Why?
|
Ossification, Heterotopic | 1 | 2017 | 239 | 0.120 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2013 | 2839 | 0.120 |
Why?
|
Neutrons | 1 | 2014 | 78 | 0.110 |
Why?
|
Proteins | 2 | 2023 | 5996 | 0.110 |
Why?
|
DNA Repair Enzymes | 1 | 2015 | 342 | 0.110 |
Why?
|
Ovarian Neoplasms | 1 | 2011 | 4900 | 0.110 |
Why?
|
Genome | 1 | 2022 | 1752 | 0.110 |
Why?
|
Pyrazoles | 2 | 2015 | 2031 | 0.110 |
Why?
|
Tumor Suppressor Proteins | 2 | 2015 | 2794 | 0.110 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2013 | 2896 | 0.100 |
Why?
|
Uniparental Disomy | 1 | 2012 | 46 | 0.100 |
Why?
|
Serbia | 1 | 2012 | 13 | 0.100 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2013 | 412 | 0.100 |
Why?
|
Ultrasonography, Prenatal | 2 | 2010 | 1772 | 0.090 |
Why?
|
Nucleotides | 2 | 2024 | 451 | 0.090 |
Why?
|
Proto-Oncogene Proteins | 2 | 2013 | 4520 | 0.090 |
Why?
|
Water Supply | 1 | 2012 | 204 | 0.090 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2011 | 370 | 0.090 |
Why?
|
Multicystic Dysplastic Kidney | 1 | 2010 | 7 | 0.090 |
Why?
|
Karyotyping | 1 | 2012 | 1176 | 0.090 |
Why?
|
Dioxygenases | 1 | 2012 | 354 | 0.090 |
Why?
|
Loss of Heterozygosity | 1 | 2012 | 663 | 0.080 |
Why?
|
beta-Thalassemia | 1 | 2012 | 233 | 0.080 |
Why?
|
Umbilical Arteries | 1 | 2010 | 78 | 0.080 |
Why?
|
Kell Blood-Group System | 1 | 2009 | 21 | 0.080 |
Why?
|
Aromatase Inhibitors | 1 | 2013 | 518 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2022 | 3651 | 0.080 |
Why?
|
Erythroblastosis, Fetal | 1 | 2009 | 62 | 0.080 |
Why?
|
Mutation | 4 | 2014 | 30184 | 0.080 |
Why?
|
Cytomegalovirus | 1 | 2013 | 751 | 0.080 |
Why?
|
Blood Group Incompatibility | 1 | 2009 | 134 | 0.080 |
Why?
|
Diagnostic Imaging | 1 | 2022 | 3526 | 0.080 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2015 | 8603 | 0.080 |
Why?
|
Cell Cycle | 2 | 2013 | 2918 | 0.080 |
Why?
|
Humans | 32 | 2024 | 765734 | 0.070 |
Why?
|
Mice | 11 | 2024 | 81792 | 0.070 |
Why?
|
Menopause | 1 | 2016 | 1661 | 0.070 |
Why?
|
RNA Splicing | 1 | 2012 | 904 | 0.070 |
Why?
|
Abruptio Placentae | 1 | 2009 | 115 | 0.070 |
Why?
|
Hedgehog Proteins | 1 | 2012 | 772 | 0.070 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2012 | 12238 | 0.070 |
Why?
|
Protons | 1 | 2013 | 1073 | 0.070 |
Why?
|
Placenta Previa | 1 | 2009 | 125 | 0.070 |
Why?
|
DNA-Binding Proteins | 3 | 2013 | 9594 | 0.070 |
Why?
|
Fagopyrum | 1 | 2006 | 1 | 0.070 |
Why?
|
Genes, Tumor Suppressor | 1 | 2011 | 1059 | 0.070 |
Why?
|
Signal Transduction | 3 | 2024 | 23589 | 0.070 |
Why?
|
Pregnancy | 6 | 2011 | 30248 | 0.070 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2012 | 3794 | 0.070 |
Why?
|
Chromosome Deletion | 1 | 2011 | 1385 | 0.070 |
Why?
|
Cytomegalovirus Infections | 1 | 2013 | 835 | 0.070 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 3247 | 0.070 |
Why?
|
Cell Differentiation | 1 | 2024 | 11641 | 0.070 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2012 | 954 | 0.070 |
Why?
|
Breast Neoplasms | 1 | 2013 | 21053 | 0.060 |
Why?
|
Fertility | 1 | 2011 | 768 | 0.060 |
Why?
|
Fetal Growth Retardation | 1 | 2010 | 591 | 0.060 |
Why?
|
Neoplasm Proteins | 2 | 2022 | 3593 | 0.060 |
Why?
|
Female | 18 | 2021 | 395961 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 2 | 2014 | 6499 | 0.060 |
Why?
|
Placenta Accreta | 1 | 2009 | 242 | 0.060 |
Why?
|
Myelodysplastic Syndromes | 2 | 2013 | 1403 | 0.060 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2013 | 1533 | 0.060 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2012 | 1241 | 0.060 |
Why?
|
Gene Regulatory Networks | 1 | 2013 | 1747 | 0.060 |
Why?
|
Repressor Proteins | 2 | 2012 | 2968 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2020 | 5336 | 0.060 |
Why?
|
Transcription Factors | 4 | 2022 | 12123 | 0.060 |
Why?
|
Exons | 3 | 2014 | 2391 | 0.050 |
Why?
|
Animals | 11 | 2024 | 168731 | 0.050 |
Why?
|
S Phase | 1 | 2024 | 424 | 0.050 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2012 | 2880 | 0.050 |
Why?
|
Cardiolipins | 1 | 2022 | 82 | 0.050 |
Why?
|
Apoptosis | 2 | 2022 | 9511 | 0.050 |
Why?
|
Disease Progression | 3 | 2017 | 13614 | 0.050 |
Why?
|
Cell Cycle Proteins | 1 | 2013 | 3431 | 0.050 |
Why?
|
Polycythemia Vera | 2 | 2013 | 160 | 0.050 |
Why?
|
Partial Pressure | 1 | 2021 | 245 | 0.050 |
Why?
|
Ultraviolet Rays | 1 | 2006 | 1099 | 0.050 |
Why?
|
Cell Degranulation | 1 | 2022 | 280 | 0.050 |
Why?
|
Oxidoreductases | 1 | 2023 | 409 | 0.040 |
Why?
|
Gases | 1 | 2021 | 206 | 0.040 |
Why?
|
Mice, Congenic | 1 | 2020 | 98 | 0.040 |
Why?
|
Gene Expression Profiling | 2 | 2015 | 9522 | 0.040 |
Why?
|
Cell Line, Tumor | 2 | 2013 | 17062 | 0.040 |
Why?
|
Histone Acetyltransferases | 1 | 2022 | 332 | 0.040 |
Why?
|
Prognosis | 3 | 2022 | 29899 | 0.040 |
Why?
|
Gene Library | 1 | 2022 | 1066 | 0.040 |
Why?
|
Leukemia, Myeloid | 2 | 2013 | 696 | 0.040 |
Why?
|
Nerve Tissue Proteins | 1 | 2011 | 4391 | 0.040 |
Why?
|
Nitriles | 2 | 2015 | 982 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7424 | 0.040 |
Why?
|
Multivariate Analysis | 1 | 2012 | 12056 | 0.040 |
Why?
|
Candida albicans | 1 | 2022 | 377 | 0.040 |
Why?
|
Antioxidants | 1 | 2006 | 1670 | 0.040 |
Why?
|
DNA | 1 | 2012 | 7200 | 0.040 |
Why?
|
Cell Count | 1 | 2022 | 1823 | 0.040 |
Why?
|
Transgenes | 1 | 2022 | 1015 | 0.040 |
Why?
|
Remission Induction | 2 | 2015 | 2409 | 0.040 |
Why?
|
Nuclear Proteins | 3 | 2022 | 5781 | 0.040 |
Why?
|
Pyrimidines | 3 | 2015 | 3044 | 0.030 |
Why?
|
Animals, Genetically Modified | 1 | 2022 | 1558 | 0.030 |
Why?
|
Antineoplastic Agents | 2 | 2020 | 13639 | 0.030 |
Why?
|
Base Sequence | 2 | 2022 | 12402 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2012 | 10428 | 0.030 |
Why?
|
Mice, Nude | 2 | 2013 | 3614 | 0.030 |
Why?
|
Phagocytosis | 1 | 2022 | 1518 | 0.030 |
Why?
|
Glucose-6-Phosphate Isomerase | 1 | 2015 | 49 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2020 | 1837 | 0.030 |
Why?
|
Benzeneacetamides | 1 | 2015 | 36 | 0.030 |
Why?
|
Pyrans | 1 | 2015 | 47 | 0.030 |
Why?
|
Cell Lineage | 1 | 2024 | 2573 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2022 | 2036 | 0.030 |
Why?
|
Adult | 7 | 2017 | 222974 | 0.030 |
Why?
|
Polymerase Chain Reaction | 2 | 2013 | 6061 | 0.030 |
Why?
|
Aged | 6 | 2021 | 171050 | 0.030 |
Why?
|
Thrombocytosis | 1 | 2013 | 87 | 0.030 |
Why?
|
Vincristine | 1 | 2015 | 1038 | 0.030 |
Why?
|
Veratrum Alkaloids | 1 | 2012 | 23 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 2023 | 3717 | 0.030 |
Why?
|
Sulfones | 1 | 2015 | 447 | 0.030 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2015 | 295 | 0.030 |
Why?
|
Genome-Wide Association Study | 1 | 2012 | 12800 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2012 | 16041 | 0.030 |
Why?
|
Dacarbazine | 1 | 2015 | 552 | 0.030 |
Why?
|
Electrons | 1 | 2014 | 265 | 0.030 |
Why?
|
Ganciclovir | 1 | 2013 | 257 | 0.030 |
Why?
|
Thermodynamics | 1 | 2014 | 580 | 0.030 |
Why?
|
Immunoblotting | 1 | 2015 | 1643 | 0.020 |
Why?
|
Pyridines | 2 | 2015 | 2889 | 0.020 |
Why?
|
Camptothecin | 1 | 2015 | 600 | 0.020 |
Why?
|
Codon | 1 | 2013 | 595 | 0.020 |
Why?
|
Janus Kinases | 1 | 2013 | 253 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2015 | 2011 | 0.020 |
Why?
|
Granulocytes | 1 | 2013 | 549 | 0.020 |
Why?
|
Bone Marrow Diseases | 1 | 2013 | 234 | 0.020 |
Why?
|
Sequence Analysis, DNA | 2 | 2013 | 4772 | 0.020 |
Why?
|
Wnt Proteins | 1 | 2015 | 722 | 0.020 |
Why?
|
Luciferases | 1 | 2012 | 713 | 0.020 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2013 | 309 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2012 | 26284 | 0.020 |
Why?
|
Medulloblastoma | 1 | 2015 | 657 | 0.020 |
Why?
|
beta Catenin | 1 | 2015 | 1042 | 0.020 |
Why?
|
Anxiety Disorders | 1 | 2021 | 2736 | 0.020 |
Why?
|
Triazoles | 1 | 2015 | 897 | 0.020 |
Why?
|
Chromatin | 1 | 2022 | 2981 | 0.020 |
Why?
|
Oxygen | 1 | 2021 | 4242 | 0.020 |
Why?
|
Fetal Monitoring | 1 | 2010 | 69 | 0.020 |
Why?
|
Pyrazines | 1 | 2015 | 1204 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2022 | 3078 | 0.020 |
Why?
|
Thrombosis | 2 | 2013 | 2949 | 0.020 |
Why?
|
Cisplatin | 1 | 2015 | 1657 | 0.020 |
Why?
|
Male | 7 | 2021 | 363585 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2022 | 3948 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2022 | 9548 | 0.020 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2013 | 697 | 0.020 |
Why?
|
Doxorubicin | 1 | 2015 | 2229 | 0.020 |
Why?
|
Random Allocation | 1 | 2013 | 2393 | 0.020 |
Why?
|
Oncogene Proteins | 1 | 2012 | 710 | 0.020 |
Why?
|
Middle Aged | 4 | 2021 | 222903 | 0.020 |
Why?
|
Genotype | 2 | 2014 | 13024 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 2013 | 1143 | 0.020 |
Why?
|
Gene Amplification | 1 | 2012 | 1089 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2023 | 14445 | 0.020 |
Why?
|
Ultrasonography, Doppler | 1 | 2010 | 460 | 0.020 |
Why?
|
Translocation, Genetic | 1 | 2013 | 1393 | 0.020 |
Why?
|
DNA, Plant | 1 | 2006 | 51 | 0.020 |
Why?
|
Infant, Newborn | 3 | 2013 | 26332 | 0.020 |
Why?
|
Neoplasms | 1 | 2015 | 22345 | 0.020 |
Why?
|
Anxiety | 1 | 2021 | 4670 | 0.020 |
Why?
|
Catalase | 1 | 2006 | 216 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 2010 | 1478 | 0.020 |
Why?
|
Pedigree | 1 | 2014 | 4524 | 0.020 |
Why?
|
Plant Leaves | 1 | 2006 | 156 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2023 | 10262 | 0.020 |
Why?
|
Lipid Peroxidation | 1 | 2006 | 275 | 0.020 |
Why?
|
Glycoproteins | 1 | 2013 | 2194 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2014 | 4106 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 4563 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2015 | 5879 | 0.020 |
Why?
|
Blotting, Western | 1 | 2012 | 5019 | 0.010 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2013 | 3605 | 0.010 |
Why?
|
Superoxide Dismutase | 1 | 2006 | 593 | 0.010 |
Why?
|
Young Adult | 3 | 2017 | 59852 | 0.010 |
Why?
|
Peroxidase | 1 | 2006 | 605 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2011 | 4618 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2012 | 3419 | 0.010 |
Why?
|
Infant | 2 | 2017 | 36363 | 0.010 |
Why?
|
Antigens, CD | 1 | 2013 | 4020 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2022 | 18289 | 0.010 |
Why?
|
Child, Preschool | 2 | 2017 | 42468 | 0.010 |
Why?
|
Alleles | 1 | 2013 | 6893 | 0.010 |
Why?
|
Adolescent | 3 | 2017 | 88781 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2015 | 11007 | 0.010 |
Why?
|
Drug Delivery Systems | 1 | 2013 | 2207 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2020 | 22321 | 0.010 |
Why?
|
Peptides | 1 | 2013 | 4331 | 0.010 |
Why?
|
Acute Disease | 1 | 2011 | 7232 | 0.010 |
Why?
|
Antiviral Agents | 1 | 2013 | 3052 | 0.010 |
Why?
|
Glioma | 1 | 2015 | 3493 | 0.010 |
Why?
|
Quality of Life | 1 | 2021 | 13462 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2012 | 17595 | 0.010 |
Why?
|
Cell Line | 1 | 2013 | 15542 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2013 | 12509 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2011 | 4912 | 0.010 |
Why?
|
Chronic Disease | 1 | 2013 | 9351 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2012 | 12769 | 0.010 |
Why?
|
Child | 2 | 2017 | 80499 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 54795 | 0.010 |
Why?
|
Prevalence | 1 | 2013 | 15833 | 0.010 |
Why?
|
Phenotype | 1 | 2014 | 16706 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2015 | 6952 | 0.010 |
Why?
|
Kidney | 1 | 2010 | 7066 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2015 | 9071 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2014 | 18061 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2015 | 65180 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2013 | 59459 | 0.000 |
Why?
|